Case report
However, this is less likely in Hochiminh City than in rural areas.
As there is a potential risk of transmission of malaria to both donor and recipient in malarious areas, both donors and recipients in these areas should receive a therapeutic course of quinine or chloroquine prior to BMT. All blood donors should receive similar treatment.
In endemic areas, spikes of fever should always lead to a blood film check.
In this case, the classical quinine antimalaria management had a dramatic effect despite the heavy parasitemia. The mefloquine given with the aim of preventing relapse was also successful for at least 15 months after BMT. This management seems to be appropriate but needs further verification.
Conditioning regimen was designed to avoid the risk of fatal infection, but it also increased the risk of rejection. The girl may have died of Plasmodium infection if the conditioning was intense enough to ensure engraftment.
Marrow engraftment jeopardised by malaria infection has not been previously recognized in man. However, susceptibility of multipotent haemopoietic stem cell deficient W/W mice to Plasmodium berghei infection has been noted. 4 The Figure 1 A 12-year-old girl with ␤-thalassemia hemoglobin E disease thalassemic haemopoietic stem cell may be more resistant had a spiking fever on day 6 after marrow transplantation and a heavy to malaria infection than the normal donor haemopoietic
Plasmodium falciparum parasitemia was detected on day 11 which stem cells, 5 and the rapid autologous recovery after BMT responded dramatically to quinine therapy.
during the period of malaria infection in this case ensured survival.
and still had hepatomegaly. Chromosome studies and genetic analyses were not performed until 15 months after
